Scilla, K. A., Bentzen, S. M., Lam, V. K., Mohindra, P., Nichols, E. M., Vyfhuis, M. A., . . . Feliciano, J. L. (2017). Neutrophil‐Lymphocyte Ratio Is a Prognostic Marker in Patients with Locally Advanced (Stage IIIA and IIIB) Non‐Small Cell Lung Cancer Treated with Combined Modality Therapy. Oncologist.
Chicago-стиль цитированияScilla, Katherine A., et al. "Neutrophil‐Lymphocyte Ratio Is a Prognostic Marker in Patients With Locally Advanced (Stage IIIA and IIIB) Non‐Small Cell Lung Cancer Treated With Combined Modality Therapy." Oncologist 2017.
MLA-цитированиеScilla, Katherine A., et al. "Neutrophil‐Lymphocyte Ratio Is a Prognostic Marker in Patients With Locally Advanced (Stage IIIA and IIIB) Non‐Small Cell Lung Cancer Treated With Combined Modality Therapy." Oncologist 2017.